Rapport Therapeutics Inc
(RAPP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,720 | -50,795 | -24,063 | -78,307 | -58,327 |
| Depreciation Amortization | 428 | -32 | -192 | -2,372 | -3,192 |
| Accounts payable and accrued liabilities | 1,037 | 1,216 | 185 | -346 | -994 |
| Other Working Capital | -105 | -3,803 | -433 | -2,416 | -3,757 |
| Other Operating Activity | 13,588 | 8,107 | 4,266 | 18,613 | 15,888 |
| Operating Cash Flow | $-62,772 | $-45,307 | $-20,237 | $-64,828 | $-50,382 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,702 | 43,940 | 21,322 | -167,736 | -199,892 |
| PPE Investments | -447 | -313 | -291 | -2,405 | -2,179 |
| Investing Cash Flow | $-13,149 | $43,627 | $21,031 | $-170,141 | $-202,071 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 270,476 | 6 | 6 | 157,712 | 157,705 |
| Common Stock Repurchased | -1 | -1 | -1 | N/A | N/A |
| Other Financing Activity | 0 | -63 | 0 | 63,913 | 63,913 |
| Financing Cash Flow | $270,475 | $-58 | $5 | $221,625 | $221,618 |
| Beginning Cash Position | 56,910 | 56,910 | 56,910 | 70,254 | 70,254 |
| End Cash Position | 251,464 | 55,172 | 57,709 | 56,910 | 39,419 |
| Net Cash Flow | $194,554 | $-1,738 | $799 | $-13,344 | $-30,835 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,772 | -45,307 | -20,237 | -64,828 | -50,382 |
| Capital Expenditure | -447 | -313 | -291 | -2,405 | -2,179 |
| Free Cash Flow | -63,219 | -45,620 | -20,528 | -67,233 | -52,561 |